Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 247372, 11 pages
http://dx.doi.org/10.1155/2014/247372
Research Article

Effect of Th17 and Treg Axis Disorder on Outcomes of Pulmonary Arterial Hypertension in Connective Tissue Diseases

1Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China
2Department of Cardiothoracic Surgery, East Hospital, Tongji University, Shanghai 200120, China
3Department of Cardiothoracic Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China

Received 22 February 2014; Revised 13 July 2014; Accepted 4 August 2014; Published 20 August 2014

Academic Editor: Alex Kleinjan

Copyright © 2014 Saren Gaowa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Simonneau, M. A. Gatzoulis, I. Adatia et al., “Updated clinical classification of pulmonary hypertension,” Journal of the American College of Cardiology, vol. 62, no. 25, supplement, pp. D34–D41, 2013. View at Google Scholar
  2. E. Hachulla, V. Gressin, L. Guillevin et al., “Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study,” Arthritis and Rheumatism, vol. 52, no. 12, pp. 3792–3800, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Mukerjee, D. St George, B. Coleiro et al., “Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach,” Annals of the Rheumatic Diseases, vol. 62, no. 11, pp. 1088–1093, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Yang, J. Mardekian, K. N. Sanders, M. A. Mychaskiw, and J. Thomas III, “Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature,” Clinical Rheumatology, vol. 32, no. 10, pp. 1519–1531, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Kuwana, H. Watanabe, N. Matsuoka, and N. Sugiyama, “Pulmonary arterial hypertension associated with connective tissue disease: meta-analysis of clinical trials,” BMJ Open, vol. 3, no. 8, Article ID e003113, 2013. View at Publisher · View at Google Scholar
  6. P. Miossec and J. K. Kolls, “Targeting IL-17 and TH17 cells in chronic inflammation,” Nature Reviews Drug Discovery, vol. 11, no. 10, pp. 763–776, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Monteleone, F. Pallone, and G. Monteleone, “Interleukin-23 and Th17 cells in the control of gut inflammation,” Mediators of Inflammation, vol. 2009, Article ID 297645, 7 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Pandolfi, R. Cianci, D. Pagliari, R. Landolfi, G. Cammarota, and S. Kunkel, “Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases,” Mediators of Inflammation, vol. 2009, Article ID 132028, 11 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Sakaguchi, “Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses,” Annual Review of Immunology, vol. 22, pp. 531–562, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Boldt, S. Borte, S. Fricke et al., “Eight-color immunophenotyping of T-, B-, and NK-cell subpopulations for characterization of chronic immunodeficiencies,” Cytometry Part B: Clinical Cytometry, vol. 86, no. 3, pp. 191–206, 2014. View at Google Scholar
  11. H. T. Maecker, J. P. McCoy, and R. Nussenblatt, “Standardizing immunophenotyping for the Human Immunology Project,” Nature Reviews Immunology, vol. 12, no. 3, pp. 191–200, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Buc, “Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis,” Mediators of Inflammation, vol. 2013, Article ID 963748, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Nie, Y. Zheng, R. Li et al., “Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis,” Nature Medicine, vol. 19, no. 3, pp. 322–328, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Garcia-Rodriguez, J. Callejas-Rubio, N. Ortego-Centeno et al., “Altered AKT1 and MAPK1 gene expression on peripheral blood mononuclear cells and correlation with T-helper-transcription factors in systemic lupus erythematosus patients,” Mediators of Inflammation, vol. 2012, Article ID 495934, 14 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Fenoglio, F. Battaglia, A. Parodi et al., “Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis,” Clinical Immunology, vol. 139, no. 3, pp. 249–257, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. A. K. Andreassen, R. Wergeland, S. Simonsen, O. Geiran, C. Guevara, and T. Ueland, “N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension,” The American Journal of Cardiology, vol. 98, no. 4, pp. 525–529, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Allanore, D. Borderie, J. Avouac et al., “High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis,” Arthritis & Rheumatism, vol. 58, no. 1, pp. 284–291, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Yang, Y. Chu, X. Yang et al., “Th17 and natural treg cell population dynamics in systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 60, no. 5, pp. 1472–1483, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. Q. Niu, B. Cai, Z. Huang, L. Wang, and Y. Shi, “Disturbed Th17/Treg balance in patients with rheumatoid arthritis,” Rheumatology International, vol. 32, no. 9, pp. 2731–2736, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Slobodin, M. S. Ahmad, I. Rosner et al., “Regulatory T cells (CD4+CD25brightFoxP3+) expansion in systemic sclerosis correlates with disease activity and severity,” Cellular Immunology, vol. 261, no. 2, pp. 77–80, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Antiga, P. Quaglino, S. Bellandi et al., “Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea,” British Journal of Dermatology, vol. 162, no. 5, pp. 1056–1063, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. T. S. Rodŕguez-Reyna, J. Furuzawa-Carballeda, J. Cabiedes et al., “Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study,” Rheumatology International, vol. 32, no. 9, pp. 2653–2660, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. T. R. D. J. Radstake, L. van Bon, J. Broen et al., “Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFβ expression,” PLoS ONE, vol. 4, no. 6, Article ID e5981, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Liu, N. Gao, M. Li et al., “Elevated levels of CD4+CD25+FoxP3+ T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction,” PLoS ONE, vol. 8, no. 6, Article ID e64531, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Xiao, S. Wang, R. Miao, and W. Kan, “TRAIL is associated with impaired regulation of CD4+CD25- T cells by regulatory T cells in patients with rheumatoid arthritis,” Journal of Clinical Immunology, vol. 31, no. 6, pp. 1112–1119, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Herrath, M. Müller, P. Amoudruz et al., “The inflammatory milieu in the rheumatic joint reduces regulatory T-cell function,” European Journal of Immunology, vol. 41, no. 8, pp. 2279–2290, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Bonelli, A. Savitskaya, C. Steiner, E. Rath, J. S. Smolen, and C. Scheinecker, “Phenotypic and functional analysis of CD4+CD25-Foxp3+ T cells in patients with systemic lupus erythematosus,” The Journal of Immunology, vol. 182, no. 3, pp. 1689–1695, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Flores-Borja, E. C. Jury, C. Mauri, and M. R. Ehrenstein, “Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 49, pp. 19396–19401, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Bonelli, A. Savitskaya, K. von Dalwigk et al., “Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE),” International Immunology, vol. 20, no. 7, pp. 861–868, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Tamosiuniene, W. Tian, G. Dhillon et al., “Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension,” Circulation Research, vol. 109, no. 8, pp. 867–879, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Shetty, C. J. Weston, Y. H. Oo et al., “Common lymphatic endothelial and vascular endothelial receptor-1 mediates the transmigration of regulatory T cells across human hepatic sinusoidal endothelium,” The Journal of Immunology, vol. 186, no. 7, pp. 4147–4155, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. M. R. Nicolls, L. Taraseviciene-Stewart, P. R. Rai, D. B. Badesch, and N. F. Voelkel, “Autoimmunity and pulmonary hypertension: a perspective,” European Respiratory Journal, vol. 26, no. 6, pp. 1110–1118, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Bettelli, Y. Carrier, W. Gao et al., “Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells,” Nature, vol. 441, no. 7090, pp. 235–238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. K. S. Voo, Y. Wang, F. R. Santori et al., “Identification of IL-17-producing FOXP3+ regulatory T cells in humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 12, pp. 4793–4798, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Beriou, C. M. Costantino, C. W. Ashley et al., “IL-17-producing human peripheral regulatory T cells retain suppressive function,” Blood, vol. 113, no. 18, pp. 4240–4249, 2009. View at Publisher · View at Google Scholar · View at Scopus